Act Two Investors’s Johnson & Johnson JNJ Stock Holding History

Act Two Investors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-72,656	Closed	-$10.5M	–	44
2024 Q4	$10.5M	Buy	+72,656	New	+$11.3M	2.05%	15
2024 Q3	–	Sell	-3,176	Closed	-$464K	–	48
2024 Q2	$464K	Sell	3,176 -330	-9%	-$49.1K	0.09%	39
2024 Q1	$555K	Sell	3,506 -8,284	-70%	-$1.32M	0.11%	37
2023 Q4	$1.85M	Buy	+11,790	New	+$1.81M	0.4%	28
2023 Q3	–	Sell	-97,001	Closed	-$16.1M	–	41
2023 Q2	$16.1M	Buy	97,001 +36,413	+60%	+$5.88M	4.49%	10
2023 Q1	$9.39M	Buy	+60,588	New	+$9.78M	3.74%	11
2021 Q4	–	Sell	-12,973	Closed	-$2.1M	–	29
2021 Q3	$2.1M	Sell	12,973 -7,315	-36%	-$1.25M	0.5%	26
2021 Q2	$3.34M	Sell	20,288 -1,205	-6%	-$199K	0.65%	26
2021 Q1	$3.53M	Buy	21,493 +154	+0.7%	+$24.9K	0.78%	23
2020 Q4	$3.36M	Buy	21,339 +2,639	+14%	+$389K	0.85%	24
2020 Q3	$2.78M	Hold	18,700	–	–	0.9%	22
2020 Q2	$2.63M	Hold	18,700	–	–	0.98%	21
2020 Q1	$2.45M	Hold	18,700	–	–	1.13%	21
2019 Q4	$2.73M	Sell	18,700 -433	-2%	-$58.7K	1.03%	24
2019 Q3	$2.48M	Buy	19,133 +433	+2%	+$57K	1.09%	24
2019 Q2	$2.6M	Hold	18,700	–	–	1.35%	24
2019 Q1	$2.61M	Hold	18,700	–	–	1.5%	22
2018 Q4	$2.41M	Buy	+18,700	New	+$2.61M	1.7%	23

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Act Two Investors's JNJ Position: Q1 2025 in Review

Act Two Investors sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 72,656 shares — an estimated $10.5M sold.

Act Two Investors first reported a position in JNJ in Q4 2018 and held it in 18 quarters. The position peaked at $16.1M in Q2 2023. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Act Two Investors reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Act Two Investors sold 72,656 Johnson & Johnson shares in Q1 2025, an estimated $10.5M.
Act Two Investors first reported a position in Johnson & Johnson in Q4 2018 and held it in 18 quarters.
Act Two Investors's Johnson & Johnson position peaked at $16.1M in Q2 2023.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Act Two Investors's 13F filing for Q1 2025, filed 12 May 2025.